Author, year | Country | Study Design | Participants | Sex | Sample size | Trial Duration (Weeks) | Means Age | Means BMI | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IG | CG | IG | CG | IG | CG | Type | Supplement dose (g/day) | CG | ||||||
Lee et al. 2007 [52] | Germany | Parallel, R, PC, DB | Patients with mild HTN | ♂/♀ | 25 | 25 | 12 | 55.3 ± 10.4 | 47.8 ± 11.6 | 28.5 ± 4.2 | 27.2 ± 4 | Milk | 3.38 | Skim milk without whey |
Keogh & Clifton. 2008 [53] | Australia | Parallel, R, PC, DB | Individuals with overweight and obesity | ♂/♀ | 34 | 38 | 48 | 49.6 ± 12.3 | 50.3 ± 12.4 | 34.4 ± 3.7 | 34.4 ± 3.7 | Whey | 15 | Skim milk powder |
Claessens et al. 2009 (a) [54] | Netherlands | Parallel, R, PC | Individuals with overweight and obesity | ♂/♀ | 14 | 16 | 12 | 45.4 ± 8.2 | 46 ± 8.8 | 32.9 ± 6 | 32.4 ± 4.8 | Casein | 50 | Maltodextrin |
Claessens et al. 2009 (b) [54] | Netherlands | Parallel, R, PC | Individuals with overweight and obesity | ♂/♀ | 18 | 16 | 12 | 44.9 ± 8.5 | 46 ± 8.8 | 33.4 ± 4 | 32.4 ± 4.8 | Whey | 50 | Maltodextrin |
Silva et al. 2010 [55] | Brazil | Parallel, R, CO, DB | Patients with ALS | ♂/♀ | 8 | 8 | 16 | 53 | 53 | 21.7 ± 1.1 | 22.9 ± 1.1 | Whey | 22 | Maltodextrin |
Pal et al. 2010 (a) [86] | Australia | Crossover, R, CO, SB | Post-menopausal women with overweight | ♀ | 20 | 20 | 3 | < 66 | < 66 | 25–40 | 25–40 | Whey | 45 | Glucose |
Pal et al. 2010 (b) [86] | Australia | Crossover, R, CO, SB | Post-menopausal women with overweight | ♀ | 20 | 20 | 3 | < 66 | < 66 | 25–40 | 25–40 | Casein | 45 | Glucose |
Pal et al. 2010 (a) [56] | Australia | Parallel, R, CO, SB | Individuals with overweight and obesity | ♂/♀ | 25 | 25 | 12 | 18–65 | 18–65 | 32 ± 4 | 30.6 ± 4.5 | Whey | 54 | Glucose |
Pal et al. 2010 (b) [56] | Australia | Parallel, R, CO, SB | Individuals with overweight and obesity | ♂/♀ | 20 | 25 | 12 | 18–65 | 18–65 | 31.3 ± 4.5 | 30.6 ± 4.5 | Casein | 54 | Glucose |
Takahira et al. 2011 [57] | Japan | Parallel, R, PC, DB | Individuals with visceral fat obesity | ♂/♀ | 23 | 21 | 32 | 54.4 ± 13 | 56.8 ± 12.2 | 29.3 ± 3.8 | 29 ± 4.5 | Milk | 9 | Soy protein |
Gouni-Berthold et al. 2012 [58] | Germany | Parallel, R, PC, DB | Patients with metabolic syndrome | ♂/♀ | 83 | 88 | 12 | 52.9 ± 10.3 | 53.9 ± 9.5 | 30.8 ± 4.2 | 31.3 ± 4 | Whey | 15 | Yogurts |
Hambre et al. 2012 [59] | Sweden | Parallel, R, CO | Healthy males | ♂ | 12 | 12 | 12 | 24.2 ± 3.7 | 23.2 ± 3.4 | 22.6 ± 2.5 | 22.3 ± 1.9 | Whey | 33 | A meal of fast food |
Sheikholeslami Vatani et al. 2012 [60] | Iran | Parallel, R, PC, SB | Young men with overweight | ♂ | 9 | 10 | 6 | 23 ± 2 | 21 ± 1 | 26.5 ± 1.2 | 27.2 ± 1.6 | Whey | 90 | Starch |
Ahmadi Kani Golzar et al. 2012 [61] | Iran | Parallel, R, PC, SB | Young men with overweight | ♂ | 10 | 10 | 6 | 22.7 ± 2.3 | 21.20 ± 1.03 | 26.5 ± 1.1 | 27.1 ± 1.5 | Whey | 30 | Starch solution |
Björkman et al. 2012 [62] | Finland | Parallel, R, CO | Nursing home residents | ♂/♀ | 46 | 51 | 24 | 84.1 ± 7.6 | 83 ± 8.7 | 24.8 ± 4.3 | 24 ± 5.5 | Whey | 20 | Regular juice |
Rambousková et al. 2014 [63] | Czech Republic | Parallel, R, CO | Elderly individuals | ♂/♀ | 23 | 24 | 8 | 84.2 ± 9.7 | 85.3 ± 9.2 | 20.3 ± 2.9 | 20.4 ± 2.8 | Milk | 18.2 | Non-intervention |
Piccolo et al. 2015 [64] | USA | Parallel, R, CO, DB | Women with obesity | ♀ | 16 | 11 | 8 | 41 ± 9.8 | 41 ± 9.8 | 36.9 ± 3.1 | 36 ± 4.8 | Whey | 20 | Gelatin |
Tahavorgar et al. 2015 [65] | Iran | Parallel, R,CO, DB | Men with overweight and obesity | ♂ | 26 | 19 | 12 | 39.4 ± 6.9 | 38.8 ± 8.8 | 32.1 ± 3.2 | 32.1 ± 2.7 | Whey | 65 | Soy protein |
Fekete et al. 2016 (a) [87] | UK | Crossover, R, CO, DB | Healthy individuals with mildly elevated BP | ♂/♀ | 38 | 38 | 8 | 52.9 ± 12.9 | 52.9 ± 12.9 | 27.1 ± 4.9 | 27.1 ± 4.9 | Whey | 56 | Maltodextrin |
Fekete et al. 2016 (b) [87] | UK | Crossover, R, CO, DB | Healthy individuals with mildly elevated BP | ♂/♀ | 38 | 38 | 8 | 52.9 ± 12.9 | 52.9 ± 12.9 | 27.1 ± 4.9 | 27.1 ± 4.9 | Casein | 56 | Maltodextrin |
Arciero et al. 2016 [66] | USA | Parallel, R, CO | Individuals with overweight | ♂/♀ | 12 | 9 | 16 | 48 ± 12 | 52 ± 4 | 32 ± 7 | 33 ± 3 | Whey | 25 | Food protein |
Maltais et al. 2016 [67] | Canada | Parallel, R,CO, DB | Sarcopenic elderly men | ♂ | 8 | 8 | 16 | 68 ± 5.6 | 64 ± 4.8 | 25.8 ± 3 | 27 ± 2.7 | Milk | 13.53 | Soy milk |
Stojkovic et al. 2017 [68] | USA | Parallel, R, PC, DB | Postmenopausal women | ♀ | 38 | 46 | 72 | 68.9 ± 5.5 | 69.3 ± 6.1 | 26 ± 3.7 | 25.8 ± 4.1 | Whey | 20 | Maltodextrin |
Lopes Gomes et al. 2017 [69] | Brazil | Parallel, R, CO | Patients after bariatric surgery (> 24 months) | ♀ | 15 | 15 | 16 | 41 ± 10 | 49 ± 10 | 36 ± 6 | 35 ± 4 | Whey | 46 | Non-intervention |
Hassan et al. 2017 [70] | Israel | Parallel, R, CO | Hypoalbuminemia peritoneal dialysis patients | ♂/♀ | 18 | 18 | 12 | 59.7 ± 11.5 | 58.1 ± 12.3 | 28.7 ± 3.3 | 28.6 ± 3.5 | Whey | 26.3 | Protein without whey |
Ottestad et al. 2017 [71] | Norway | Parallel, R, PC, DB | Older adults | ♂/♀ | 17 | 19 | 12 | 76.8 ± 6.2 | 77.1 ± 4.7 | 27.6 ± 4.2 | 25.9 ± 4.9 | Milk | 40 | Carbohydrate |
Lockwood et al. 2017 (a) [72] | USA | Parallel, R, PC, DB | Healthy college-aged males | ♂ | 15 | 15 | 8 | 21.8 ± 3.5 | 20.9 ± 1.5 | NR | NR | High-lactoferrin-Whey | 60 | Carbohydrate |
Lockwood et al. 2017 (b) [72] | USA | Parallel, R, PC, DB | Healthy college-aged males | ♂ | 13 | 15 | 8 | 21.3 ± 2.5 | 20.9 ± 1.5 | NR | NR | Whey | 60 | Carbohydrate |
Lockwood et al. 2017 (c) [72] | USA | Parallel, R, PC, DB | Healthy college-aged males | ♂ | 13 | 15 | 8 | 21.5 ± 3.2 | 20.9 ± 1.5 | NR | NR | Extensively hydrolyzed whey | 60 | Carbohydrate |
Gaffney et al. 2018 [73] | New Zealand | Parallel, R, PC, DB | Patients with T2DM | ♂ | 12 | 12 | 10 | 53.5 ± 5.6 | 57.8 ± 5.2 | 29.6 ± 2.7 | 30.1 ± 4.9 | Whey | 28.5 | Carbohydrate |
Sharp et al. 2018 [74] | USA | Parallel, R, CO, DB | Healthy participants | ♂/♀ | 10 | 10 | 8 | 19 ± 2 | 21 ± 2 | NR | NR | Whey | 46 | Maltodextrin |
Larsen et al. 2018 [75] | Denmark | Parallel, R, CO, SB | Individuals with overweight and obesity | ♂/♀ | 14 | 15 | 4 | 41 | 41 | 34.9 ± 5.4 | 35.1 ± 5.8 | Whey | 41 | Maltodextrin |
Derosa et al. 2019 [76] | Italy | Parallel, R, PC, DB | Patients with T2DM | ♂/♀ | 59 | 58 | 12 | 59.7 ± 9.1 | 58.6 ± 8.8 | 22.7 ± 2.1 | 22.7 ± 2.1 | Whey | 9.25 | Placebo (5 g caseins) |
Nabuco et al. 2019 [77] | Brazil | Parallel, R, PC, DB | Older women with sarcopenic obesity | ♀ | 13 | 13 | 12 | 68 ± 4.2 | 70.1 ± 3.9 | 26.4 ± 3 | 27.4 ± 3 | Whey | 35 | Maltodextrin |
Giglio et al. 2019 [78] | Brazil | Parallel, R, PC, DB | Women with overweight | ♀ | 17 | 20 | 8 | 37.8 ± 12 | 43 ± 8 | 31.1 ± 4 | 30.9 ± 3.6 | Whey | 40 | Collagen |
Yang et al. 2019 (a) [79] | China | Parallel, R, CO | Individuals with pre or mild HTN, and normal weight | ♂/♀ | 12 | 12 | 12 | 42.37 ± 11.6 | 43.8 ± 11.7 | 24.1 ± 3.1 | 24.3 ± 2.3 | Whey | 30 | Maltodextrin |
Yang et al. 2019 (b) [79] | China | Parallel, R, CO | Individuals with pre or mild HTN, overweight, and obesity | ♂/♀ | 15 | 15 | 12 | 42.37 ± 11.6 | 43.8 ± 11.7 | 24.1 ± 3.1 | 24.3 ± 2.3 | Whey | 30 | Maltodextrin |
Hudson et al. 2020 [80] | USA | Parallel, R, PC, DB | Individuals with overweight and obesity | ♂/♀ | 21 | 23 | 16 | 53 ± 9.2 | 52 ± 4.8 | 31 ± 3.2 | 30.3 ± 3.4 | Milk | 64 | Maltodextrin |
Haidari et al. 2020 [81] | Iran | Parallel, R, CO | Pre-menopausal women with obesity on a weight-loss diet | ♀ | 30 | 30 | 8 | 31 ± 6.2 | 32.2 ± 5.1 | 33.5 ± 3.17 | 33.3 ± 2.6 | Whey | 30 | Isocaloric weight-loss diet |
Lefferts et al. 2020 [82] | USA | Parallel, R, CO, DB | Older adults | ♂/♀ | 53 | 46 | 12 | 69 ± 7 | 67 ± 6 | 27.9 ± 5.6 | 27 ± 3.9 | Whey | 50 | Carbohydrate |
Fuglsang-Nielsen et al. 2021 (a) [83] | Denmark | Parallel, R, CO, DB | Individuals with abdominal obesity | ♂/♀ | 15 | 16 | 12 | 64 | 64 | NR | NR | Whey + low fiber | 60 | Maltodextrin + low fiber |
Fuglsang-Nielsen et al. 2021 (b) [83] | Denmark | Parallel, R, CO, DB | Individuals with abdominal obesity | ♂/♀ | 17 | 17 | 12 | 64 | 64 | NR | NR | Whey + high fiber | 60 | Maltodextrin + high fiber |
Pettersson et al. 2021 [84] | Sweden | Parallel, R, PC.DB | Untrained men with overweight or obesity | ♂ | 10 | 10 | 6 | 28.2 ± 5.5 | 27.9 ± 5 | 29.8 ± 2.3 | 30.4 ± 1.8 | Milk | 10 | Carbohydrate |
Teixeira et al. 2022 [85] | Portugal | Parallel, R, CO, DB | Futsal players | ♂ | 20 | 20 | 8 | 18–35 | 18–35 | NR | NR | Whey | 25 | Plant-based protein |